Alcon Site Directory

Our Science
Our Business
Our Products
Careers
Contact Us

English

A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radioisotope Therapy for Patients With Neuroendocrine Tumors

×

Work in progress

Advanced Accelerator Applications, a Novartis Company

Our Science

Our Pipeline
Nuclear Medicine
Clinical Trials

Our Business

Radioligand Therapy
Molecular Imaging
History
Ethics, Risk and Compliance

News

AAA State of California Declaration of Compliance
Careers
Careers old
Clinical Trials
Commitment to Integrity
Contact form
Contact Us
Expanding our patient reach in Spain with the new Salamanca site
France
History
Home
Legal notice
Molecular Imaging
News
Nuclear Medicine
Our Products
Our Sites
Partnerships-uk
Partnerships-us
Pharmacovigilance
Privacy Policy
Quality and Traceability
Terms and Conditions

Our Products
Careers
Contact Us

Stay Connected

© 2024 Advanced Accelerator Applications, A Novartis Company

Legal notice, Terms of Use, Privacy Policy, About Cookies, Cookie Preferences